Iron supplementation associated with loss of phenotype in autosomal dominant hypophosphatemic rickets.

CONCLUSIONS: We report an association between iron supplementation and a complete loss of biochemical ADHR phenotype, allowing withdrawal of rickets medication. Experience from this case suggests that reduction and withdrawal of rickets medication should be attempted only once iron status has been optimized. PMID: 26186302 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26186302?dopt=Abstract

Source: Diabetes Metab - July 17, 2015 Category: Endocrinology Authors: Kapelari K, Köhle J, Kotzot D, Högler W Tags: J Clin Endocrinol Metab Source Type: research

More News: Diabetes | Endocrinology | Genetics | Girls | Iron